BREAKING NEWS
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
ADO (cysteamine dioxygenase) is a unique enzyme whose substrates include both proteins and metabolites! We were curious about the role of ADO in cancer and normal cells. Excited to share our paper published today: https://t.co/nT386rdz6Z
I would love an ELO-based restaurant ranking system
Yelp reviews aren’t very useful. Everything is 3.5 - 4.5 stars. Tells me nothing. Same for Google Maps. The 0-5 scale just doesn’t get used properly because of social norms toward high ratings.
What would work much better is…
The value of ‘wasting time’ on deep thinking is often overlooked in a scientific ecosystem increasingly tainted by Wall Street’s productivity mindset.
https://t.co/hNTA74DNOr
After significant efforts led by @IvanKlyuzhin, our paper is finally published: "Relating Macroscopic PET #Radiomics Features to Microscopic Tumor Phenotypes Using a Stochastic Mathematical Model of Cellular Metabolism and Proliferation"
https://t.co/vnVcIdxgpe
Hailey Ahn et al.
Are you looking for a PhD programme on tumour immunology and immunotherapy?
We are hiring!
Sanquin Research is looking for a PhD candidate who will join the Foskolou lab to investigate novel ways to make CAR-T cell therapy better for solid tumours.
https://t.co/K67DThSyzw
It’s finally out 🎉! Our study on how low oxygen levels sensed by CD8+ T cells during activation modulate T cell function and can be harnessed to improve immunotherapeutic efficacy @eLife https://t.co/K1GFED3pig. Here's the tweetorial ⬇️⬇️⬇️(1/n)
More interesting insights into T cell biology from the @camkiphysiology group, this time NO synthesis. And of course the importance of oxygen and hypoxia! Great work @pedrocunha37 and @pedrovelica
Eleanor and the @camkiphysiology group show that glutarate is a regulator of cellular metabolism and aKG dependent dioxygenases with significant effects on T cell function. https://t.co/XNO4MGab4q
Lecanemab phase 3 Clarity AD study in early Alzheimer’s disease meets primary and all key secondary endpoints with high statistical significance https://t.co/tkK0y2vHXo